Fecal matter for preventing or treating intestinal microbiome aberrations in cesarean section-born infants

Abstract

A composition for use in the prevention or treatment of intestinal microbiota aberration in a Cesarean section- (CS-) born infant, wherein the use is particularly for one or more of reducing intestinal colonization of pathogenic microorganisms, increasing intestinal relative abundance of Bacteroides species and/or Bifidobacterium species, increasing intestinal microbial diversity, increasing level of intestinal secretory IgA and/or intestinal antimicrobial peptides, reducing susceptibility to a disorder particularly chosen from the group consisting of metabolic disease, obesity, type 2 diabetes, auto-immune disease, atopy-related disease, allergy and asthma, and increasing immune response to vaccines.

Dependencies are inferred from the claim text.